Cargando…

Clinical and genetic determinants of nevirapine plasma trough concentration

BACKGROUND: Only few data are available on the influence of CYP2B6 and CYP3A4/A5 polymorphisms on nevirapine plasma concentrations in the Caucasian population. Our aim was to assess the impact of CYP2B6 and CYP3A4/A5 polymorphisms on nevirapine plasma concentrations consecutively collected. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales:	Giacomelli, Andrea, Rusconi, Stefano, Falvella, Felicia Stefania, Oreni, Maria Letizia, Cattaneo, Dario, Cozzi, Valeria, Renisi, Giulia, Monge, Elisa, Cheli, Stefania, Clementi, Emilio, Riva, Agostino, Galli, Massimo, Ridolfo, Anna Lisa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5992792/ https://www.ncbi.nlm.nih.gov/pubmed/29899984 http://dx.doi.org/10.1177/2050312118780861

Ejemplares similares

Clinical and genetic factors associated with increased risk of severe liver toxicity in a monocentric cohort of HIV positive patients receiving nevirapine-based antiretroviral therapy
por: Giacomelli, Andrea, et al.
Publicado: (2018)

LightSNiP assay is a good strategy for pharmacogenetics test
por: Cheli, Stefania, et al.
Publicado: (2015)

Clinical and genetic factors associated with kidney tubular dysfunction in a real-life single centre cohort of HIV-positive patients
por: Salvaggio, S. E., et al.
Publicado: (2017)

Consumption of antibiotics at an Italian university hospital during the early months of the COVID-19 pandemic: Were all antibiotic prescriptions appropriate?
por: Giacomelli, Andrea, et al.
Publicado: (2021)

Durability of INI-containing regimens after switching from PI-containing regimens: a single-centre cohort of drug-experienced HIV-infected subjects
por: Giacomelli, Andrea, et al.
Publicado: (2019)

Estimating the effectiveness of remdesivir on risk of COVID-19 mortality: The role of observational data
por: Giacomelli, Andrea, et al.
Publicado: (2022)

Does lopinavir really inhibit SARS-CoV-2?
por: Cattaneo, Dario, et al.
Publicado: (2020)

Impact of switching to TAF/FTC/RPV, TAF/FTC/EVG/cobi and ABC/3TC/DTG on cardiovascular risk and lipid profile in people living with HIV: a retrospective cohort study
por: Giacomelli, Andrea, et al.
Publicado: (2021)

Therapeutic Drug Monitoring of Anti-TNFα Inhibitors: A Matter of Cut-Off Ranges
por: Cheli, Stefania, et al.
Publicado: (2023)

Trend in the proportion of subjects with SARS-CoV-2 infection without COVID-19 specific symptoms among patients admitted to a COVID-19 referral hospital
por: Giacomelli, Andrea, et al.
Publicado: (2023)

Evolution of the SARS-CoV-2 epidemic: From genomic surveillance to new health needs
por: Giacomelli, Andrea, et al.
Publicado: (2023)

Pharmacogenetic Practice of Anticancer Drugs: Multiple Approaches for an Accurate and Comprehensive Genotyping
por: Montrasio, Cristina, et al.
Publicado: (2023)

Undetected Toxicity Risk in Pharmacogenetic Testing for Dihydropyrimidine Dehydrogenase
por: Falvella, Felicia Stefania, et al.
Publicado: (2015)

Metabolic and Kidney Disorders Correlate with High Atazanavir Concentrations in HIV-Infected Patients: Is It Time to Revise Atazanavir Dosages?
por: Gervasoni, Cristina, et al.
Publicado: (2015)

Drug–Drug Interactions and Prescription Appropriateness in Patients with COVID-19: A Retrospective Analysis from a Reference Hospital in Northern Italy
por: Cattaneo, Dario, et al.
Publicado: (2020)

Low influenza vaccination coverage among hospitalized COVID-19 patients in Milan: A gap to be urgently filled
por: Ridolfo, Anna Lisa, et al.
Publicado: (2021)

Factors involved in treatment durability and immunological recovery in a cohort of HIV-positive patients receiving atazanavir-based regimens
por: Giacomelli, Andrea, et al.
Publicado: (2014)

Is COVID-19 severity associated with anti-spike antibody duration? Data from the ARCOVID prospective observational study
por: Borgonovo, Fabio, et al.
Publicado: (2021)

Development of an HPLC–UV assay method for the simultaneous quantification of nine antiretroviral agents in the plasma of HIV-infected patients()
por: Charbe, Nitin, et al.
Publicado: (2016)

Definition of the Immune Parameters Related to COVID-19 Severity
por: Birindelli, Sarah, et al.
Publicado: (2022)

Corrigendum: Definition of the immune parameters related to COVID-19 severity
por: Birindelli, Sarah, et al.
Publicado: (2023)

30-day mortality in patients hospitalized with COVID-19 during the first wave of the Italian epidemic: A prospective cohort study
por: Giacomelli, Andrea, et al.
Publicado: (2020)

SARS-CoV-2 viremia and COVID-19 mortality: A prospective observational study
por: Giacomelli, Andrea, et al.
Publicado: (2023)

Low Body Weight in Females Is a Risk Factor for Increased Tenofovir Exposure and Drug-Related Adverse Events
por: Gervasoni, Cristina, et al.
Publicado: (2013)

Neonatal Outcomes in Maternal Depression in Relation to Intrauterine Drug Exposure
por: Corti, Silvia, et al.
Publicado: (2019)

Milan’s forgotten epidemic of summer 1629, a few months before the last great plague: An investigation into the possible cause
por: Galli, Massimo, et al.
Publicado: (2023)

Darunavir does not prevent SARS-CoV-2 infection in HIV patients
por: Riva, Agostino, et al.
Publicado: (2020)

Twelfth-Position Deuteration of Nevirapine Reduces 12-Hydroxy-Nevirapine Formation and Nevirapine-Induced Hepatocyte Death
por: Heck, Carley J. S., et al.
Publicado: (2020)

Drug–Drug Interactions and Prescription Appropriateness at Hospital Discharge: Experience with COVID-19 Patients
por: Cattaneo, Dario, et al.
Publicado: (2021)

Combined isosorbide dinitrate and ibuprofen as a novel therapy for muscular dystrophies: evidence from Phase I studies in healthy volunteers
por: Cossu, Maria Vittoria, et al.
Publicado: (2014)

Remdesivir in moderate to severe COVID-19: A matter of time?
por: Bonazzetti, Cecilia, et al.
Publicado: (2021)

Differences in the Prevalence of SARS-CoV-2 Infection and Access to Care between Italians and Non-Italians in a Social-Housing Neighbourhood of Milan, Italy
por: Pagani, Gabriele, et al.
Publicado: (2021)

Treatment outcome in HIV+ patients receiving 3- or 4-drug regimens during PHI
por: Maria Bottani, Giulia, et al.
Publicado: (2014)

Evaluation of residual humoral immune response against SARS-CoV-2 by a surrogate virus neutralization test (sVNT) 9 months after BNT162b2 primary vaccination()
por: Pezzati, Laura, et al.
Publicado: (2023)

Incidence and Determinants of Nevirapine and Efavirenz-Related Skin Rashes in West Africans: Nevirapine's Epitaph?
por: Sarfo, Fred Stephen, et al.
Publicado: (2014)

Solid-State Characterization of Nevirapine
por: Sarkar, Mahua, et al.
Publicado: (2008)

Compassionate remdesivir treatment of severe Covid-19 pneumonia in intensive care unit (ICU) and Non-ICU patients: Clinical outcome and differences in post-treatment hospitalisation status
por: Antinori, Spinello, et al.
Publicado: (2020)

Inflammation and neurological adverse drugs reactions: a case of long lasting impaired consciousness after oxatomide administration in a patient with gastroenteritis
por: Antoniazzi, Stefania, et al.
Publicado: (2012)

Of waves and troughs
por: Noll-Hussong, Michael
Publicado: (2014)

Preparation and Characterisation of Nevirapine Oral Nanosuspensions
por: Raju, Anju, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_jtq5isa7u39esemitn71mget3r